Corpus Intelligence IC Memo — KFH - REDWOOD CITY 2026-04-26 17:26 UTC
IC Memo — KFH - REDWOOD CITY
Investment Committee Memorandum | CA | 140 beds | Grade C | EBITDA uplift $27.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KFH - REDWOOD CITY

CCN 050541 | SAN MATEO, CA | 140 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KFH - REDWOOD CITY is a 140-bed suburban community hospital in SAN MATEO, CA with $379.7M in net patient revenue and a -4.5% operating margin. The hospital serves a payer mix of 3.5% Medicare, 1.1% Medicaid, and 95.4% commercial.

Thesis: Undervalued. Our ML models identify $27.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.5% to 2.9% (+736bps).

Net Revenue HCRIS$379.7M
Current EBITDA COMPUTED$-17.1M
Operating Margin COMPUTED-4.5%
Occupancy HCRIS57.0%
Revenue / Bed COMPUTED$2.7M
Net-to-Gross HCRIS30.6%
Distress Probability ML42.7%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
197
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -4.5% places it above the state median. Among 197 size-comparable peers (70-280 beds), the median margin is -3.9%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (70-280), prioritizing same-state peers. 197 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KFH - REDWOOD CITY (Target)CA140$379.7M-4.5%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
CALIFORNIA PACIFIC MEDICAL CENCA274$987.8M-18.5%
ENLOE MEDICAL CENTERCA258$834.4M-0.5%
KFH - SOUTH SACRAMENTOCA233$803.9M5.9%
COMMUNITY HOSP. MONTEREY PENINCA227$797.2M9.3%
KFH - MANTECACA213$796.8M15.2%
LAC OLIVE VIEW/UCLA MEDICAL CECA225$754.9M-10.5%
MARIAN MEDICAL CENTERCA252$751.5M4.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$8.0M+210bp18mo
Cost to Collect4.5%2.5%$7.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.6M+122bp9mo
Clean Claim Rate88.0%96.0%$243K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$8.0M
Cost to Collect
$7.6M
Denial Rate Reduction
$7.5M
A/R Days Reduction
$4.6M
Clean Claim Rate
$243K
Total EBITDA Uplift$27.9M
Current EBITDA$-17.1M
+ RCM Uplift+$27.9M
Pro Forma EBITDA$10.8M
Current Margin-4.5%
Pro Forma Margin2.9%
WC Released (1x)$14.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-26.3M$166.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-26.3M$174.8M0.00x-100.0%
Bull Case9.0x11.0x$-23.7M$258.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-23.7M$275.0M0.00x-100.0%
Bear Case11.0x10.0x$-28.9M$35.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-28.9M$29.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 197 hospitals with 70-280 beds
  • Same-state prioritization (n=198)
  • Comp margins: P25=-18.1% / P50=-3.9% / P75=4.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.